Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Franklin Genomic Advancements Fund N (acc) USD Fonds 113697895 / LU2387456168

5.80 USD
0.11 USD
1.93 %
5.2.2025
NAV

Nettoinventarwert (NAV)

5.80 USD 0.11 USD 1.93 %
Vortag 5.69 USD Datum 05.02.2025

Franklin Genomic Advancements Fund N (acc) USD Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 388.08%
21Shares Stellar ETP CH1109575535 262.62%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Algorand ETP CH1146882316 160.84%
21Shares The Sandbox ETP CH1177361008 134.26%
21Shares Sui Staking ETP CH1360612159 84.39%
21Shares Injective Staking ETP CH1360612134 -16.01%
21Shares Immutable ETP CH1360612142 -23.58%
Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 442.24%
21Shares Ripple XRP ETP CH0454664043 411.84%
21Shares Stellar ETP CH1109575535 290.27%
21Shares Aave ETP CH1135202120 197.58%
21Shares Algorand ETP CH1146882316 170.14%
21Shares Stacks Staking ETP CH1258969042 145.10%
21Shares Injective Staking ETP CH1360612134 -28.15%
21Shares Immutable ETP CH1360612142 -37.27%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 386.55%
21Shares Aave ETP CH1135202120 212.40%
21Shares Stellar ETP CH1109575535 206.11%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 184.30%
21Shares Bitcoin Core ETP CH1199067674 129.92%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 743.17%
21Shares Ripple XRP ETP CH0454664043 481.66%
21Shares Bitcoin Core ETP CH1199067674 313.98%
21Shares Bitcoin ETP CH0454664001 303.50%
21Shares Crypto Basket Equal Weight (HODLV) ETP CH1135202161 275.02%

Fundamentaldaten

Valor 113697895
ISIN LU2387456168
Emittent Franklin Templeton International Services
Aufgelegt in Luxembourg
Auflagedatum 15.10.2021
Kategorie Branchen: Gesundheitswesen
Währung USD
Volumen 3’011’165.14
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 30.06.
Berichtsstand 04.02.2025

Anlagepolitik

So investiert der Franklin Genomic Advancements Fund N (acc) USD Fonds: The Fund's investment objective is capital appreciation. The Fund invests principally in equity securities of companies that are relevant to the Fund’s investment theme of genomic advancements. Equity securities generally entitle the holder to participate in a company's general operating results. While the Fund invests predominantly in common stocks, it could also invest in preferred stock, convertible securities and warrants on securities.

ETP Performance: Franklin Genomic Advancements Fund N (acc) USD Fonds

Performance 1 Jahr
0.87
Performance 2 Jahre
-7.50
Performance 3 Jahre
-24.97
Performance 5 Jahre -
Performance 10 Jahre -